Active substances
Dutasteride + Tamsulosin
- SFDA 3
- US FDA 5
- Health Canada 1
- US price lines 1
- NHS prices 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| DUODART Capsule | 0.5,0.4 mg,mg | Capsule, hard · Oral use | 30 Tablet Container | SAR 103.60 | NCE · Prescription | Glaxo Saudi Arabia Ltd | Valid |
| Dusta plus | 0.5,0.4 mg,mg | Capsule, hard · Oral use | 30 Bottle | SAR 90.45 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| DUODART Capsule | 0.4, 0.5 mg | Capsule, hard · Oral use | 90 Tablet Container | SAR 388.50 | NCE · Prescription | Glaxo Saudi Arabia Ltd | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
BENIGN PROSTATIC HYPERTROPHY
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| JALYN | 0.5MG;0.4MG | capsule · oral | WAYLIS THERAP | Prescription | 14 Jun 2010 |
| DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE | 0.5MG;0.4MG | capsule · oral | ZYDUS PHARMS | Prescription | 24 May 2018 |
| DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE | 0.5MG;0.4MG | capsule · oral | AUROBINDO PHARMA | Prescription | 18 Jul 2024 |
| DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE | 0.5MG;0.4MG | capsule · oral | PH HEALTH | Discontinued | 26 Feb 2014 |
| DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE | 0.5MG;0.4MG | capsule · oral | ACTAVIS LABS FL INC | Discontinued | 20 Nov 2015 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| JALYN | 02372010 | 0.5 MG; 0.4 MG | CAPSULE (IMMEDIATE- AND EXTENDED-RELEASE · ORAL | GLAXOSMITHKLINE INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | DUTASTERIDE-TAMSULOSIN 0.5-0.4 | $1.97362 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Tamsulosin 400microgram / Dutasteride 500microgram capsules | £4.35 | 30 capsule | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.